Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 81.60
+0.85 (1.05%)
At close: Jan 16, 2026
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.4 billion as of January 16, 2026. Its market cap has increased by 3.44% in one year.
Market Cap
1.40B
Enterprise Value
1.31B
Revenue
179.28M
Ranking
n/a
PE Ratio
41.83
Stock Price
€81.60
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.40B, a decrease of -21.95%. That is a compound annual growth rate of -2.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.40B | 8.95% |
| Dec 31, 2025 | 1.29B | -7.20% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.61B |
| Laboratorios Farmaceuticos Rovi | 3.53B |
| Almirall | 2.81B |
| Faes Farma | 1.62B |
| Clínica Baviera | 829.43M |
| Oryzon Genomics | 257.85M |
| Atrys Health | 232.18M |
| Prim, S.A. | 225.46M |